99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: Novel imaging agents for rapid in vivo localization of human colon carcinoma

Journal of Nuclear Medicine

Volumn 42, Issue 10, 2001, Pages 1519-1527

  Goel, A ^a   Baranowska Kortylewicz, J ^a   Hinrichs, S H ^a   Wisecarver, J ^a   Pavlinkova, G ^a   Augustine, S ^a   Colcher, D ^a   Booth, B J M ^a   Batra, S K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

99mTc; Biodistribution; Macroautoradiography; Multivalency; Single chain Fv

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CC49; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TUMOR ANTIGEN; ANTIBODY CONJUGATE; B72.3 ANTIBODY; CANCER ANTIBODY; DIAGNOSTIC AGENT; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN FV; TECHNETIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER DIAGNOSIS; CANCER LOCALIZATION; COLON CARCINOMA; GENETIC ENGINEERING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOREACTIVITY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RADIOIMMUNOASSAY; ANIMAL; CELL CULTURE; COLON TUMOR; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; NUDE MOUSE; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AUTORADIOGRAPHY; COLONIC NEOPLASMS; GENETIC ENGINEERING; IMMUNOCONJUGATES; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, NUDE; RADIOIMMUNODETECTION; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0034740816     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Improving the balance between treatment and diagnosis: A role for radioimmunodetection
2. The development of new radiopharmaceuticals
3. Transport of molecules across tumor vasculature
4. Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen
5. 99mTc: Fire role of metabolism and kinetics
6. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab′ fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody
7. 99mTc-labeled LL2-Fab′ (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma
8. 2 and Fab′ fragments relative to immunoglobulin G in reactions with surface-bound antigens
9. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts
10. Single-chain antigen-binding proteins
11. In vivo tumor targeting of a recombinant single-chain antigen-binding protein
12. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
13. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms
14. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: Potential clinical applications for radioimmunoguided surgery and gamma scanning
15. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms
16. Effects of genetic engineering on the pharmacokinetics of antibodies
17. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: Expression, purification, and characterization
18. Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: Improved biodistribution and potential for therapeutic application
19. Protein measurement by Folin phenol
20. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
21. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats
22. Single-chain Fv radioimmunotargeting
23. Taking engineered anti-CEA antibodies to the clinic
24. Single chain antigen binding protein (sFv CC49): First human studies in colorectal carcinoma metastatic to liver
25. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library
26. Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine
27. Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging
28. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
29. Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: A comparison with two other technetium-labelled immunoglobulin preparations
30. 99mTc-labeled monoclonal antibody G250 preparations
31. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: Comparison with indium-111-DTPA-IgG
32. Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: A clinical study
33. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex
34. Chemical and biological characterization of different Tc complexes of cysteine and cysteine derivatives
35. Directly and indirectly technetium-99m-labeled antibodies: A comparison of in vitro and animal in vivo properties
36. Cysteine, a chelating moiety for synthesis of technetium-99m radiopharmaceuticals. 11. Attempt to synthesize renal tubular radiopharmaceuticals
37. Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells
38. Identification of the sites of 1gG catabolism in the rat
39. Hepatic clearance mechanism of Tc-99m-HIDA and its effect on quantitation of hepatobiliary function: Concise communication
40. Relative position of the hexahistidine tag effects binding properties of a tumor-associated single-chain Fv construct